---
figid: PMC5075022__18_2016_2297_Fig3_HTML
figlink: /pmc/articles/PMC5075022/figure/Fig3/
number: F3
caption: Loss of negative feedback contributes to resistance to Raf and MEK1/2 inhibitors.
  Raf or MEK1/2 inhibition (1) results in lower levels of negative feedback to upstream
  components (2). As a result, the cell is returned to an RTK signalling-competent
  state, where Ras and other upstream factors are able to respond to signal activation
  (3). Therefore, signal flux is increased (4), promoting higher ERK1/2 activity and
  requiring higher inhibitor doses. The increased Ras activity can also activate parallel
  pathways, such as the PI3K/Akt pathway (5). In addition, loss of negative feedback
  leads to the de-repression of other RTK receptors (6), allowing different growth
  factors to activate downstream signalling pathways. Activation of the PI3K/Akt pathway
  can promote cell survival (7) and reduce the dependency of the tumour on ERK1/2
  signalling, likely contributing to the acquired resistance to Raf and MEK1/2 inhibitors
pmcid: PMC5075022
papertitle: Negative feedback regulation of the ERK1/2 MAPK pathway.
reftext: David Lake, et al. Cell Mol Life Sci. 2016;73(23):4397-4413.
pmc_ranked_result_index: '53558'
pathway_score: 0.9630348
filename: 18_2016_2297_Fig3_HTML.jpg
figtitle: Loss of negative feedback contributes to resistance to Raf and MEK1/2 inhibitors
year: '2016'
organisms:
- Homo sapiens
ndex: cfd074aa-dec5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5075022__18_2016_2297_Fig3_HTML.html
  '@type': Dataset
  description: Loss of negative feedback contributes to resistance to Raf and MEK1/2
    inhibitors. Raf or MEK1/2 inhibition (1) results in lower levels of negative feedback
    to upstream components (2). As a result, the cell is returned to an RTK signalling-competent
    state, where Ras and other upstream factors are able to respond to signal activation
    (3). Therefore, signal flux is increased (4), promoting higher ERK1/2 activity
    and requiring higher inhibitor doses. The increased Ras activity can also activate
    parallel pathways, such as the PI3K/Akt pathway (5). In addition, loss of negative
    feedback leads to the de-repression of other RTK receptors (6), allowing different
    growth factors to activate downstream signalling pathways. Activation of the PI3K/Akt
    pathway can promote cell survival (7) and reduce the dependency of the tumour
    on ERK1/2 signalling, likely contributing to the acquired resistance to Raf and
    MEK1/2 inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - AKT1
  - AKT2
  - DUSP1
  - NRAS
  - ARAF
  - RAF1
  - DUSP2
  - MAP2K2
  - MAP2K1
  - DUSP3
  - BRAF
  - PIK3R3
  - PIK3R6
  - AKT3
  - KSR1
  - KSR2
  - SHC4
  - MAPK3
  - PIK3R5
  - SHC2
  - PIK3CG
  - SOS2
  - MAPK1
  - GRB2
  - DUSP4
  - DUSP5
  - DUSP6
  - SHC3
  - PIK3CD
  - SOS1
  - PIK3CB
  - PIK3R4
  - PIK3CA
  - SHC1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2E1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: KSR1/2
  symbol: KSR1
  source: hgnc_symbol
  hgnc_symbol: KSR1
  entrez: '8844'
- word: KSR1/2
  symbol: KSR2
  source: hgnc_symbol
  hgnc_symbol: KSR2
  entrez: '283455'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5075022__F3
redirect_from: /figures/PMC5075022__F3
figtype: Figure
---
